1,796 material Form 8-K filings that 1,448 companies we cover made with the SEC in May 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
American Airlines, Inc. and parent American Airlines Group Inc. signed a Twelfth Amendment to their 2015 credit agreement, refinancing existing term loans in full with $1,146.8 million of new term loans and adding $703.2 million of incremental term loans. The new loans carry a higher spread than the SOFR-based or base-rate options specified in the filing and mature on May 29, 2033, so the airline's total term debt under this facility increases, which shareholders should weigh against the longer maturity.
Refinancing term loans: $1,146.8 million, replacing existing term loans in full
Incremental term loans: $703.2 million, bringing total 2026 term loans to about $1.85 billion
Interest: base rate plus 2.00% margin, or three-month SOFR plus 3.00% margin, both with 0.00% floors
Maturity May 29, 2033; annual repayments of 1.00% starting on the first anniversary
Solana Company entered into an amended sales agreement with Clear Street LLC and Maxim Group LLC on May 29, 2026, raising the aggregate gross sales price of Class A shares it may sell under its at-the-market offering from $92.8 million to $250 million. The filing states that no sales are obligated and that no assurance is given any shares will be sold, so the change adds capacity for share issuance that could dilute existing shareholders if used.
Offering capacity increased from $92.8 million to $250 million, excluding shares sold under the prior prospectus supplement.
As of May 29, 2026, the company had sold shares for aggregate gross proceeds of $24,657,697.51 under the prior arrangement.
Agents may be paid commissions of up to 3.00% of gross proceeds from each sale.
Cooley LLP issued a legal opinion on the validity of the shares; the agreement was filed as Exhibit 10.1.
NeoVolta issued 12,195,122 common shares at $2.05 each on May 29, 2026, in an underwritten public offering led by Lake Street Capital Markets. The company expects net proceeds of approximately $23.5 million, which it plans to use for joint venture obligations, working capital and general corporate purposes. The issuance adds new shares that dilute existing holders, and the company also disclosed a non-binding letter of intent with an existing investor for about 1.1 GWh of utility-scale battery storage supply.
12,195,122 shares sold at $2.05 per share; underwriters hold a 30-day option for up to 1,829,268 more shares
Net proceeds of approximately $23.5 million excluding any option exercise, after estimated offering expenses; underwriting discount is 6.0%
Company agreed not to issue or sell additional shares for sixty days after May 27, 2026; executive officers and directors are also subject to lock-up agreements
May 26, 2026 non-binding letter of intent with Infinite Grid Capital covering about 1.1 GWh across three initial projects; no purchase obligation until definitive agreements are signed
Encore Capital Group issued €325.0 million of senior secured floating rate notes due July 15, 2033, under an indenture dated May 28, 2026. The notes are secured by substantially all of the company's and guarantors' assets and bear interest at three-month EURIBOR (0% floor) plus 3.250% per annum. The filing describes new debt financing and does not report any use of proceeds or effect on earnings.
Principal: €325.0 million aggregate principal amount, issued May 28, 2026
Interest: three-month EURIBOR (0% floor) plus 3.250% per annum, reset quarterly
First interest payment July 15, 2026; maturity July 15, 2033
Trustee GLAS Trust Company LLC; security agent Truist Bank; secured by substantially all company and guarantor assets
Navient Corporation completed a public offering of $500 million in aggregate principal amount of 9.375% senior notes due 2031 on May 29, 2026. The notes were issued under a 2014 base indenture as supplemented, with The Bank of New York Mellon as trustee, and add $500 million of new direct debt for shareholders to weigh.
Offering size: $500 million aggregate principal amount of 9.375% senior notes due 2031, completed May 29, 2026
Underwriting agreement dated May 26, 2026, with BofA Securities, Barclays Capital, J.P. Morgan Securities and RBC Capital Markets as representatives of the underwriters
Notes issued under a base indenture dated July 18, 2014, amended by a seventeenth supplemental indenture dated May 29, 2026, with The Bank of New York Mellon as trustee
Offering made under a Form S-3 shelf registration filed May 2, 2025
Xylem completed a $1 billion public offering of two series of senior unsecured notes on May 29, 2026. The company plans to use the 2033 notes' proceeds to repay its $500 million 3.250% notes due November 1, 2026, and the 2036 proceeds to fund eligible blue projects, which adds debt that shareholders will need to see serviced.
$500 million of 5.200% Senior Notes due June 1, 2033
$500 million of 5.450% Senior Blue Notes due June 1, 2036
Proceeds from the 2033 notes intended to repay $500 million of 3.250% notes maturing November 1, 2026
Interest payable semiannually on June 1 and December 1, starting December 1, 2026
LyondellBasell subsidiaries amended the structured accounts receivables facility, effective June 26, 2026. The amendment extends the facility's term to June 25, 2027 and reduces the maximum amount available from $900 million to $700 million. The filing says no receivable purchases or letters of credit were outstanding as of May 29, 2026.
Maximum amount available cut from $900 million to $700 million
Facility term extended to June 25, 2027
Amendment effective June 26, 2026; agreement signed May 29, 2026
No trade receivable purchases or letters of credit outstanding as of May 29, 2026
On May 28, 2026, Tyler Technologies entered into an amended and restated unsecured revolving credit agreement of up to $1 billion, maturing May 28, 2031, with Wells Fargo Bank as administrative agent. The new facility replaces the company's existing $700 million credit agreement from September 2024, which was scheduled to mature in September 2029, and Tyler had no borrowings outstanding under either facility at closing.
Revolving credit facility of up to $1 billion, unsecured, maturing May 28, 2031, replacing the $700 million facility dated September 25, 2024
No borrowings were outstanding under either the new or the 2024 credit agreement at closing
Uncommitted accordion allows an increase of up to the greater of $525 million or 100% of prior four-quarter EBITDA, plus additional debt up to a 3.25 to 1.00 total net leverage ratio
Loan pricing ranges from SOFR plus 1.125% to 1.75% or prime plus 0.125% to 0.75%, based on total net leverage; the commitment fee is initially 0.125%
Ashland Inc. signed a Second Amended and Restated Credit Agreement on May 28, 2026, providing a $500 million five-year unsecured revolving credit facility that the company and its Swiss subsidiary can draw on for working capital and general corporate purposes. The filing says the agreement amends and restates Ashland's July 22, 2022 credit agreement, and it sets the initial borrowing spread and commitment fee at levels that move with the company's leverage ratio.
Revolving facility of $500 million over five years, including a $125 million letter of credit sublimit
Initial interest margin of Term SOFR or EURIBOR plus 1.375%, moving between 1.250% and 1.750% based on the Consolidated Net Leverage Ratio
Initial unused commitment fee of 0.175% per annum, moving between 0.125% and 0.275%
Agreement replaces the Amended and Restated Credit Agreement dated July 22, 2022; facility may be prepaid without premium
Research Alliance Corporation III, a blank check company, closed its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share on May 21, 2026, generating gross proceeds of $75 million before underwriting discounts and offering expenses. The full $75 million was deposited in a trust account for public shareholders, and the company has not yet selected a business combination target.
IPO of 7,500,000 Class A ordinary shares at $10.00 per share, closed May 21, 2026
Private placement of 275,000 Class A shares to sponsor Research Alliance Holdings III LLC for $2.75 million
$75 million placed in trust account with Continental Stock Transfer & Trust Company as trustee
Company has 24 months from IPO closing to complete a business combination, per the filing's Note 1
Kennametal completed a $300 million sale of 5.800% senior notes due May 28, 2036, with net proceeds of about $295.9 million. The company plans to use the proceeds to fund its concurrent tender offer for its 4.625% senior notes due 2028, with any excess used for general corporate purposes.
Notes: $300,000,000 aggregate principal, 5.800% coupon, due May 28, 2036
Estimated net proceeds of approximately $295,932,716 after underwriters' discount and offering expenses
Proceeds earmarked to buy 2028 Notes tendered in a concurrent tender offer; excess may repay other debt
Underwriters include BofA Securities, BNP Paribas Securities and PNC Capital Markets, under an agreement dated May 19, 2026
PBF Energy's subsidiary PBF Holding issued $500.0 million of 7.250% senior unsecured notes due June 1, 2034, netting about $492.7 million after discounts and expenses. The company plans to use the proceeds and available cash to fully redeem its outstanding 6.00% senior notes due 2028, which refinances existing debt and adds $500.0 million of new long-term borrowing.
Notes: $500.0 million principal, 7.250%, due June 1, 2034; interest paid semi-annually from December 1, 2026
Net proceeds of approximately $492.7 million after initial purchasers' discount and offering expenses
Proceeds and available cash to fund full redemption of 6.00% senior unsecured notes due 2028
Indenture includes limits on additional debt, dividends and share repurchases, asset sales and affiliate transactions
On May 27, 2026, ADT subsidiaries borrowed $100 million of additional first lien term A loans under an existing credit agreement with Fifth Third Bank as administrative agent, bringing term A loans outstanding to about $422,969,000. The same day, shareholders re-elected three directors, approved executive compensation on an advisory basis, and ratified PricewaterhouseCoopers LLP as auditor, after two Apollo-designated directors withdrew following Apollo's sale of all its ADT common stock.
$100 million of incremental first lien term A loans incurred May 27, 2026; about $422,969,000 outstanding after the add-on
Proceeds will be used for general corporate purposes
Thomas Gartland, Danielle Tiedt and Sigal Zarmi re-elected; Apollo designees Nicole Bonsignore and Reed B. Rayman withdrawn as nominees
Shareholders approved executive compensation and ratified PricewaterhouseCoopers LLP for fiscal year ending December 31, 2026
Woodward entered a Third Amended and Restated Credit Agreement that keeps up to $1 billion of revolving commitments and extends their termination date from October 21, 2027 to May 28, 2031. On the same day it also entered a $250 million term loan maturing May 28, 2031, and borrowed $413 million under the revolver and the full $250 million under the term loan. Shareholders should note the higher borrowing, which carries a maximum leverage ratio covenant and default acceleration terms.
Revolving commitments of up to $1 billion extended from October 21, 2027 to May 28, 2031
$413 million revolver borrowing on May 28, 2026, used with cash on hand to repay the existing revolving credit agreement and pay fees
$250 million term loan borrowed May 28, 2026, for working capital and general corporate purposes, maturing May 28, 2031
Loans bear interest at adjusted term SOFR plus 0.875% to 1.75%, and both agreements include a maximum leverage ratio covenant
On May 26, 2026, TVA completed a lease-purchase of its Cumberland Combined Cycle Generation Facility in Stewart County, Tennessee. The buyer, Cumberland Combined Cycle Generation LLC, is funded by $200 million of equity and $1.8 billion of secured notes, and TVA will receive $1,931,875,011 at closing; TVA will lease the plant back for 30 years and make semiannual rent payments through May 15, 2056. Separately, the board cut maximum payouts under its executive incentive plans, effective for fiscal years 2025 to 2027.
On or about May 26, 2026, CCCGL pays TVA $1,931,875,011 under the Head Lease and Construction Management Agreement, with $68,124,989 deposited with a lease indenture trustee.
CCCGL funds the deal with $200 million of equity and $1.8 billion of secured notes; TVA plans to use its proceeds for its power program and transaction expenses.
TVA leases the facility back for 30 years, with rent paid each May 15 and November 15 from November 15, 2026 through May 15, 2056; the first debt-portion rent is $62,416,544.
The Executive Annual Incentive Plan maximum payout falls from 225% to 150% of target, and the Long-Term Incentive Plan maximum falls from 200% to 150% of grant.
Hennessy Advisors delivered a notice of full redemption on its outstanding 4.875% notes due 2026, which have $40.25 million in principal outstanding. Holders will receive 100% of principal plus accrued and unpaid interest on June 30, 2026, after which the notes will stop accruing interest and be delisted from Nasdaq. The filing describes a repayment of existing debt in full rather than a change in the company's operations or results.
Aggregate outstanding principal of the notes is $40.25 million as of the notice date.
Redemption price is 100% of principal plus accrued and unpaid interest to, but not including, June 30, 2026.
After redemption, no notes will remain outstanding and the notes will cease to trade on Nasdaq under symbol HNNAZ.
Maximus entered into a Second Amendment to its credit agreement with JPMorgan Chase Bank, N.A., as administrative agent, on May 27, 2026. The amendment provides $325 million of new Tranche B-1 term loans, an increase to the existing term B loans, which the company may use to repay revolving loans, repurchase its capital stock, fund working capital, and pay fees. The added debt increases the company's borrowings, and shareholders will bear the cost of the loans, though the filing does not state how the proceeds will be split among these uses.
New Tranche B-1 Term Loans totaling $325,000,000 added as an increase to existing term B loans
Loans have the same terms as the existing term B loans under the Credit Agreement
Proceeds may repay revolving loans, repurchase capital stock, fund working capital, and pay fees and expenses
Amendment dated May 27, 2026; full text filed as Exhibit 10.1
Host Hotels & Resorts amended its distribution agreement for selling up to $600 million of common stock, extending its expiration from May 31, 2026 until the earlier of a $600 million sale, company termination, or termination by the agents or purchasers. The company has not sold any shares under the agreement to date, so the amendment sets no current dilution, but it keeps the option open for future equity sales.
Amendment dated May 27, 2026 extends the agreement's expiration from May 31, 2026.
Program covers up to $600 million of common stock, par value $0.01 per share, and no shares have been sold to date.
Settlement for shares sold is updated to the next business day (T+1); no other terms changed.
PENN Entertainment entered a fourth amendment to its credit agreement on May 28, 2026, repricing and extending its $962.5 million term loan B facility to May 2033. The amendment lowers the term loan B interest rate margins, which reduces borrowing costs on that facility, while the term loan A and revolving facility maturities are unchanged.
Term loan B facility of $962.5 million now matures in May 2033.
Term SOFR loan margin falls from 2.50% to 2.00%.
Base rate loan margin falls from 1.50% to 1.00%.
Term loan A and revolving facility maturities remain unchanged.
Kinder Morgan entered into an Amended and Restated Revolving Credit Agreement on May 21, 2026, with Barclays Bank PLC as administrative agent, replacing its $3.5 billion revolving credit facility. The amendment extends the maturity from August 20, 2026 to May 21, 2031 and raises swingline loan capacity from $50 million to $400 million, giving the company longer-dated committed borrowing capacity.
Facility size referenced in the filing: $3.5 billion revolving credit agreement dated August 20, 2021
Stated maturity extended from August 20, 2026 to May 21, 2031
Swingline loan capacity increased from $50 million to $400 million
Agreement dated May 21, 2026; 8-K signed May 28, 2026 by CFO David P. Michels
On May 22, 2026, Royalty Pharma signed a new $1.8 billion unsecured revolving credit agreement with Bank of America, N.A. as administrative agent, replacing its September 15, 2021 facility in full. The new facility matures May 22, 2031, and the filing lists financial covenants that shareholders can track.
Facility size is $1.8 billion, unsecured, with Bank of America, N.A. as administrative agent
Replaces the Existing Credit Agreement dated September 15, 2021; all obligations under it were repaid and its commitments terminated
Maturity date is May 22, 2031
Covenants require a consolidated leverage ratio at or below 4.00 to 1.00 and a coverage ratio of at least 2.50 to 1.00
Ares Holdings L.P. and certain Ares Management subsidiaries signed Amendment No. 14 to the company's credit agreement on May 21, 2026. The amendment extends the facility's maturity to May 21, 2031 and raises revolver commitments to $2.5 billion, with an uncommitted accordion feature up to $3.0 billion total. The filing describes this as a change to the borrowing terms, with no new obligation amount beyond the revolver commitments.
Maturity extended to May 21, 2031
Revolver commitments increased to $2.5 billion; uncommitted accordion up to $3.0 billion total facility size
Credit spread adjustment for Term SOFR removed; covenant restrictions and events of default modified
Amendment dated May 21, 2026, with JPMorgan Chase Bank, N.A. as agent
On May 27, 2026, Alamo Group Inc. entered into a Fourth Amended and Restated Credit Agreement with Bank of America, N.A. as administrative agent, allowing borrowings of up to $602,500,000. The company has already borrowed $202,500,000 under a term facility, and up to $400,000,000 is available under a revolving facility, with both expiring May 27, 2031. The agreement adds direct debt obligations that carry interest at variable rates and require the company to meet a maximum net leverage ratio and a minimum fixed charge coverage ratio.
Total availability up to $602,500,000; $202,500,000 already borrowed under the term facility
Up to $400,000,000 available under the revolving facility, with commitment fees of 0.125% to 0.30% on unused amounts
Term facility requires equal quarterly principal payments of $1,265,625; facilities expire May 27, 2031
Interest at Term SOFR or base rate plus a margin of 1.25% to 2.25% for SOFR borrowings, based on net leverage
Amanat Acquisition Corp, a blank check company, completed its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share on May 20, 2026. The $75,000,000 raised was placed in a trust account for public shareholders, and the company has 24 months from the IPO closing to complete a business combination, with no target selected as of the filing.
IPO of 7,500,000 Class A ordinary shares at $10.00 per share closed May 20, 2026, for gross proceeds of $75,000,000
Private placement of 300,000 shares to Amanat Sponsor Holdings LLC at $10.00 per share raised $3,000,000
$75,000,000 held in trust account; underwriters have a 45-day option to buy up to 1,125,000 additional shares
Audited balance sheet as of May 20, 2026 shows cash of $2,224,975; company has 24 months to complete a business combination
On May 26, 2026, Teleflex and certain subsidiaries entered into a new credit agreement that refinances their existing Third Amended and Restated Credit Agreement dated November 4, 2022. The new agreement includes a five-year $1.0 billion revolving credit facility, a $500 million term A-1 loan and a $700 million term A-2 loan, and is secured by substantially all assets. The filing states the company must keep its total net leverage ratio at or below 4.50 to 1.00 and its interest coverage ratio at or above 3.00 to 1.00.
Five-year revolving credit facility of $1.0 billion, plus a $500 million term A-1 loan maturing May 26, 2031 and a $700 million term A-2 loan maturing May 26, 2028.
Loans bear interest at Term SOFR plus 1.125% to 2.00%, or an alternate base rate plus 0.125% to 1.00%, adjusted based on net leverage or corporate family rating.
Covenants require a maximum total net leverage ratio of 4.50 to 1.00 and a minimum interest coverage ratio of 3.00 to 1.00.
Obligations are guaranteed by substantially all material domestic subsidiaries and secured by a lien on substantially all assets.
National HealthCare entered a credit agreement on May 26, 2026, providing a $475.0 million senior unsecured term loan and a $50.0 million revolving credit facility. The company expects to draw the full term loan to help fund its purchase of assets and real property from National Health Investors, with closing currently anticipated on or around July 1, 2026. The filing does not report earnings, so shareholders can weigh the new debt against the acquisition's size and the stated closing conditions.
Term loan of $475.0 million and revolving facility of $50.0 million, both maturing five years after the Funding Date
Proceeds expected to help fund the Transaction with National Health Investors under an April 21, 2026 purchase agreement
Commitments terminate automatically if the Funding Date has not occurred by August 31, 2026
Existing credit agreement with Bank of America to be repaid in full at initial funding; no amounts were outstanding as of March 31, 2026
Artelo Biosciences entered a sales agreement with H.C. Wainwright & Co. allowing it to sell up to $6,530,000 of common stock through an at-the-market program, paying the agent a 3.0% commission on gross sales. Separately, Craft Capital Management filed a FINRA arbitration claim against the company over a right of first refusal tied to a March 2026 private placement. The stock sales could dilute existing shareholders, and the outcome of the arbitration is not addressed in the filing.
Sales agreement dated May 26, 2026 allows sales of up to $6,530,000 of common stock, par value $0.001 per share
Sales agent receives a 3.0% commission on gross sales price; company has no obligation to sell any shares
Craft Capital seeks an $880,000 success fee, warrants valued at $880,000, monthly late fees and attorneys' fees over the March 30, 2026 private placement, which raised gross proceeds of about $11 million
JPMorgan Chase said it will redeem all 200,000 outstanding shares of its 3.65% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series KK, on June 1, 2026, under the optional redemption provisions of the governing documents. The shares are represented by 2,000,000 depositary shares, and holders will receive the redemption price of $10,000 per share ($1,000 per depositary share). June 1, 2026 is also the final dividend payment date for the series, so holders of these depositary shares will receive their last scheduled dividend when the redemption is paid.
200,000 Series KK preferred shares, represented by 2,000,000 depositary shares, will be redeemed on June 1, 2026
Redemption price is $10,000 per preferred share, equivalent to $1,000 per depositary share
June 1, 2026 is the final dividend payment date; the dividend record date is May 4, 2026
Payment is made through Computershare Inc., as Depositary, upon surrender of depositary receipts
Minerva Neurosciences entered a Sales Agreement with Leerink Partners LLC for an at-the-market offering of up to $75.0 million of common stock, with a 3.0% commission on gross proceeds. The company is not obligated to sell any shares, so the program could dilute existing shareholders if used. The filing also says the relapse assessment phase of its Phase 3 C19 trial of roluperidone was extended from 40 weeks to 52 weeks after FDA feedback, with topline results still expected in the second half of 2027.
Up to $75.0 million of common stock may be sold through Leerink Partners LLC, under a prospectus supplement dated May 27, 2026
Agent commission is 3.0% of gross proceeds; the company has no obligation to sell any shares
Relapse assessment phase of the C19 trial extended from 40 weeks to 52 weeks after FDA feedback
Topline efficacy results still expected in the second half of 2027; relapse assessment data in the second half of 2028
On May 27, 2026, Entergy New Orleans, LLC issued and sold $90 million of First Mortgage Bonds in two series to institutional investors in a private placement. The bonds carry fixed rates of 5.91% and 6.65% and are a new debt obligation for the utility subsidiary of Entergy.
$35 million of 5.91% First Mortgage Bonds due June 1, 2036
$55 million of 6.65% First Mortgage Bonds due June 1, 2056
Interest is payable semi-annually on June 1 and December 1, starting December 1, 2026
Bonds were issued under the 1987 Mortgage and Deed of Trust and a Twenty-sixth Supplemental Indenture dated May 1, 2026
NextNav Inc. said it will redeem all outstanding public warrants for $0.01 per warrant in cash on June 26, 2026, at 5 p.m. New York City time. Holders can still exercise the warrants for cash at $11.50 per share of common stock until the redemption date, and any unexercised warrants will be redeemed for $0.01 each. The company said the action simplifies its capital structure, and the filing states that private placement warrants are not subject to the redemption.
Redemption price is $0.01 per public warrant, payable in cash, with a redemption date of June 26, 2026, at 5 p.m. New York City time.
Warrant holders can exercise at $11.50 per share until the redemption date, and the company's notice says exercise is voluntary and must be arranged through a broker.
The company cited a common stock closing price of $23.02 on May 26, 2026, and a last sale price of at least $18.00 for 20 trading days within the 30-day period ending May 21, 2026, as the basis for the redemption right.
Approximately 10 million warrants were outstanding as of May 26, 2026, according to the press release.
American Tower completed a registered public offering of 750.0 million euros of 4.000% senior unsecured notes due September 1, 2033, with net proceeds of about 742.7 million euros (approximately $866.7 million). The company plans to use the proceeds to repay borrowings under its revolving credit facility drawn in euros, repay its 500.0 million euro 1.950% notes due 2026, and for general corporate purposes. The filing is a debt financing that adds new borrowing obligations, with covenants limiting mergers, asset sales and liens.
Principal: 750.0 million euros; 4.000% coupon, payable annually in euros from September 1, 2026
Net proceeds approximately 742.7 million euros (about $866.7 million at 1.00 euro = $1.1669)
Proceeds to repay euro revolver borrowings and 500.0 million euro 1.950% notes due 2026, plus general corporate purposes
Notes callable at any time; make-whole applies before July 1, 2033, with a 101% repurchase price upon a Change of Control and Ratings Decline
Data Storage Corp entered into an Equity Distribution Agreement with Maxim Group LLC on May 26, 2026, allowing it to sell common stock through Maxim over time. The ATM Prospectus covers up to $10,600,000 of shares, and the company is not obligated to sell any shares, so the deal could dilute existing shareholders if sales occur.
Agreement dated May 26, 2026 with Maxim Group LLC; Maxim earns a 2.5% commission on gross proceeds from each share sale.
ATM Prospectus relates to up to $10,600,000 of common stock under shelf registration Form S-3 (File 333-280881), declared effective July 26, 2024.
Company must pay up to $25,000 in specified expenses plus $2,500 in legal fees for Maxim on each Bringdown Date.
The company is not required to sell any shares, and the filing gives no assurance on sale timing, price or amount.
Burtech Acquisition Corp II, a Cayman Islands blank check company, closed its initial public offering of 8,000,000 units at $10.00 per unit on May 26, 2026, for gross proceeds of $80,000,000. A total of $80,400,000 was placed in a trust account, and the funds will not be released until the company completes an initial business combination, redeems public shares, or liquidates.
IPO closed May 26, 2026: 8,000,000 units at $10.00 per unit, gross proceeds of $80,000,000.
$80,400,000 placed in a trust account maintained by Continental Stock Transfer & Trust Company.
Sponsor and third-party investors bought 252,000 private placement units at $10.00 for $2,520,000.
Company has 15 months from the IPO closing to complete a business combination, extendable up to 21 months; four directors were appointed May 21, 2026.
Lincoln International, Inc. and its selling stockholders completed the initial public offering of 24,207,486 Class A common shares at $20.00 per share on May 21, 2026, including 3,157,498 shares from the underwriters' option. The company received gross proceeds of $473.7 million before underwriting discounts and commissions, and the filing says its charter and bylaws became effective on May 19, 2026.
Offering of 24,207,486 Class A shares at $20.00 per share, completed May 21, 2026, including 3,157,498 shares from the underwriters' option
Gross proceeds to the company of $473.7 million, before underwriting discounts and commissions
M. Christie Smith and John W. Oleniczak appointed to the board effective May 19, 2026
Charter authorizes 650,000,000 Class A, 250,000,000 Class B, 100,000,000 Class C and 5,000,000 preferred shares
The fund sold $50 million of Series A Mandatorily Redeemable Preferred Shares due April 30, 2031, and agreed to sell $40 million of 5.364% Series C Senior Notes due July 8, 2030. Proceeds will mainly refinance existing debt, including redeeming 2.35% Series A Senior Notes maturing July 8, 2026, and fund new portfolio investments; the preferred holder gains the right to elect two trustees.
Series A preferred: 2,000,000 shares at $25.00 liquidation preference, $50 million gross proceeds, due April 30, 2031
Series C Senior Notes: $40 million at a fixed 5.364% rate, maturing July 8, 2030, with proceeds used to redeem 2.35% Series A Senior Notes maturing July 8, 2026
Preferred purchaser may elect two trustees; Ira P. Cohen nominated as a Class III Trustee
Annual shareholder meeting set for September 25, 2026; record date July 10, 2026
Editas Medicine agreed to sell 55,555,556 shares of common stock, each paired with a common stock warrant, at a combined price of $2.25, with net proceeds estimated at $117.0 million. The company said the proceeds, together with its cash as of March 31, 2026, should fund operations into the second half of 2028, and the warrants could add about $192.5 million if fully exercised for cash, which would also dilute existing holders.
Gross offering size of about $125.0 million before underwriting discounts and offering expenses, with closing expected on or about May 27, 2026
Cash runway extended to the second half of 2028, based on current plans and assumptions the company says may prove wrong
Warrants have a $3.50 per share exercise price and expire on the earlier of 30 days after Phase 1 EDIT-401 data showing at least three patients with greater than 80% LDL-cholesterol reduction, or three years from issuance
Starwood Property Trust closed a private offering of $600 million in 6.125% unsecured senior notes due June 1, 2031, on May 26, 2026. The company intends to use the net proceeds for eligible green and social projects and, pending that allocation, to redeem $400 million of 3.625% notes due 2026 and for general corporate purposes. The new debt adds to the company's obligations, while the refinancing would replace notes maturing in 2026.
Principal amount of $600 million, priced May 11, 2026, closed May 26, 2026
Interest at 6.125% per year, paid semi-annually on June 1 and December 1, starting December 1, 2026
Proceeds may repay $400 million of 3.625% Senior Notes due 2026 and outstanding repurchase facility debt
Notes are unsecured, not guaranteed by subsidiaries at issuance, with a covenant requiring Total Unencumbered Assets of at least 120% of unsecured debt
On May 22, 2026, World Acceptance entered into a Consent and Limited Modification with Bank of Montreal, as administrative agent, and the Required Lenders under its July 22, 2025 revolving credit agreement. The modification temporarily lowers the minimum fixed charge ratio for three quarters, and the original 2.25 to 1.0 requirement returns for the quarter ending December 31, 2026. The filing does not state the reason for the modification.
Modified minimum ratio: 2.20 to 1.0 for the quarter ending March 31, 2026; 2.10 to 1.0 for June 30, 2026; and 2.15 to 1.0 for September 30, 2026
Original requirement of not less than 2.25 to 1.0 resumes for the quarter ending December 31, 2026
Agreement dated May 22, 2026, with Bank of Montreal as administrative agent and collateral agent
All other terms of the credit agreement remain in full force
Shimmick Corporation sold 4,289,500 common shares at $3.50 each in an underwritten public offering led by Roth Capital Partners, after the underwriter exercised its full option to buy 559,500 additional shares. The company received net proceeds of approximately $14.0 million after the underwriting discount and estimated offering expenses, and the offering closed on May 26, 2026. New shares increase the number outstanding, so existing holders' ownership percentage is reduced, while the company gains cash.
Offering agreement with Roth Capital Partners, LLC dated May 22, 2026; public offering price $3.50 per share
Total shares sold 4,289,500, including 559,500 shares from the underwriter's option
Net proceeds of approximately $14.0 million; offering closed May 26, 2026
Sold under a Form S-3 shelf registration declared effective July 10, 2025
On May 26, 2026, Florida Power & Light Company, NextEra Energy's utility subsidiary, sold $255,394,000 principal amount of Floating Rate Notes due June 1, 2076. The filing is administrative: it reports the sale and files legal opinions from two law firms as exhibits, and it does not describe any change to the company's results or outlook.
Principal amount sold: $255,394,000 on May 26, 2026
Interest rate: Compounded SOFR minus 0.35%, calculated quarterly
Notes registered under Registration Statement Nos. 333-278184, 333-278184-01 and 333-278184-02
Exhibits filed: legal opinions from Squire Patton Boggs (US) LLP and Morgan, Lewis & Bockius LLP, both dated May 26, 2026
Urban Outfitters and certain domestic subsidiaries signed a fifth amendment on May 19, 2026 to its asset-based revolving credit facility. The amendment extends the facility's maturity to May 2031 and removes the Canadian sub-facility, with its Canadian subsidiary released from obligations under the facility.
Facility continues to provide loans and letters of credit up to $350 million, subject to a borrowing base of eligible accounts receivable and inventory
Maturity date extended to May 2031
Canadian Borrowing Base and Canadian Sublimit removed; URBN Canada Retail, Inc. released from its obligations under the facility
Obligations remain unconditionally guaranteed by the Company and certain U.S. subsidiaries and secured by first-priority interest in inventory, accounts receivable and certain other assets
Assembly Biosciences sold 3,358,602 common shares at $26.50 each and pre-funded warrants for up to 415,000 shares, and underwriters exercised in full a 566,040-share option on May 22, 2026. The offering closed on May 26, 2026, with the company reporting net proceeds of approximately $107.4 million. The company plans to use the proceeds for clinical development of pipeline candidates and general corporate purposes, and the new shares increase the number of shares outstanding for existing shareholders.
Closed May 26, 2026, including the full exercise of a 566,040-share underwriter option on May 22, 2026.
Common shares priced at $26.50; pre-funded warrants for up to 415,000 shares priced at $26.499 each.
Gross proceeds of approximately $115.0 million; net proceeds of approximately $107.4 million after underwriting discounts and offering expenses.
Executive officers and directors agreed to a 90-day lock-up, subject to exceptions and Guggenheim Securities' consent to sell.
Lamb Weston's Chinese subsidiary, LW Ulanqab, entered into a RMB 700 million term loan facility with HSBC Bank (China) on May 19, 2026, maturing May 22, 2031. The loan repaid and replaced its 2022 facility, which was terminated May 22, 2026, and the parent company guarantees the obligations. The filing reports refinancing of existing debt rather than a new borrowing for other uses, and it does not disclose any earnings or guidance changes.
Term loan of RMB 700 million, about $102.94 million at the May 19, 2026 exchange rate, maturing May 22, 2031
Interest at the five-year prime rate published by the PRC National Interbank Funding Center plus 0.30%
Amortization payments begin 6 months after the initial borrowing, with the remaining principal due at maturity
The 2022 Facility Agreement dated February 18, 2022 was repaid and terminated on May 22, 2026
AmeriGas Partners and AmeriGas Finance Corp., indirect wholly owned subsidiaries of UGI, issued $500.0 million of 6.875% senior unsecured notes due 2031 on May 20, 2026. The proceeds, with other funds, are being used to redeem the 2027 notes, repurchase up to $175.0 million of 9.375% notes due 2028, and repay $150.0 million of an intercompany loan. The filing shows a new debt issue replacing or reducing existing higher-cost debt, with the company reporting no earnings impact.
$500.0 million of 6.875% senior unsecured notes due 2031 issued May 20, 2026; semi-annual interest begins December 1, 2026
Holders tendered $468,471,000 of 2027 notes; remaining 2027 notes to be redeemed June 10, 2026
$224,771,000 of 2028 notes tendered by the May 22, 2026 early deadline against a $175.0 million cap; proration factor about 77.9%
Initial settlement for accepted 2028 notes set for May 27, 2026 at $1,023.44 per $1,000 principal
Encore Capital Group issued $750.0 million of 6.625% senior secured notes due June 1, 2032, under an indenture dated May 22, 2026. The notes are guaranteed by substantially all material subsidiaries and secured by substantially all of the company's and guarantors' assets, adding to the company's secured debt.
Principal amount: $750.0 million, issued May 22, 2026
Interest rate 6.625% per year, paid semi-annually on June 1 and December 1, starting December 1, 2026
Maturity June 1, 2032, unless repurchased or redeemed earlier
Indenture names GLAS Trust Company LLC as trustee and Truist Bank as security agent; full indenture filed as Exhibit 4.1
On May 22, 2026, SiTime completed a registered offering of $1.35 billion of 0% convertible senior notes due June 15, 2031, including $150 million from the underwriters' over-allotment option. Per the pricing release, net proceeds were expected to fund part of the cash consideration for the Renesas timing business acquisition, the $108.0 million cost of capped call transactions, and general corporate purposes, which adds significant debt and potential share dilution for shareholders.
Principal of $1.35 billion, including $150 million of over-allotment notes, due June 15, 2031
Initial conversion price of approximately $1,040.47 per share, a premium of about 50% to the May 19, 2026 closing price
Cost of capped call transactions was $108.0 million; capped call cap price is $1,734.15 per share
Proceeds expected to partly fund the Renesas Electronics timing business acquisition announced February 4, 2026
Energy Transition Special Opportunities, a blank check company, closed its initial public offering of 15,000,000 units at $10.00 per unit on May 18, 2026, for gross proceeds of $150 million. A total of $150.75 million ($10.05 per unit), including $6 million in deferred underwriting commissions, was placed in a trust account for public shareholders, and the company has not commenced any operations.
IPO of 15,000,000 units at $10.00 per unit, generating $150 million gross proceeds, consummated May 18, 2026
Private placement of 5,375,000 warrants at $1.00 each, generating $5,375,000, sold to the sponsor and to Cohen & Company Capital Markets
$150.75 million ($10.05 per unit) placed in trust with Continental Stock Transfer & Trust Company as trustee
Total transaction costs of $9,598,172; the company has 18 months, or 24 months in some cases, to complete a business combination
On May 22, 2026, PepsiCo terminated its two existing $5 billion revolving credit agreements from May 2025, both of which had no outstanding borrowings, and entered into replacements of the same $5 billion size. The new facilities are a 364-day agreement expiring May 21, 2027 and a five-year agreement expiring May 22, 2031, and they are for general corporate purposes, so the filing describes a routine refinancing of existing liquidity rather than a change in borrowing.
Two new $5 billion unsecured revolving credit agreements dated May 22, 2026, replacing agreements dated May 23, 2025
364-day facility expires May 21, 2027; five-year facility expires May 22, 2031
Both facilities can be increased to up to $5.75 billion; the five-year facility includes a $1.2 billion Euro swing line subfacility
Citibank, N.A. is administrative agent; no outstanding borrowings existed under the terminated agreements
Peace Acquisition Corp, a blank check company, priced an initial public offering of 6,000,000 units at $10.00 per unit, according to a press release filed with this 8-K and dated May 21, 2026. The units are set to begin trading on Nasdaq on May 22, 2026 under the ticker PECEU, and the company plans to search for an acquisition target focused on Asia, excluding Mainland China, Hong Kong and Macau.
Priced 6,000,000 units at $10.00 per unit, announced May 21, 2026; units to trade on Nasdaq from May 22, 2026 as PECEU.
Each unit includes one ordinary share, one right to receive one-fifth of an ordinary share on completing a business combination, and one warrant to buy an ordinary share for $11.50.
Underwriters hold a 45-day option to buy up to 900,000 additional units; EarlyBirdCapital, Inc. is book-running manager.
Registration statement declared effective May 14, 2026; the company will not combine with businesses based in or principally operating in Mainland China, Hong Kong or Macau.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.